Eli Lilly has defended the advertising
Effects of GLP-1 and Its Analogs on Gastric Physiology in Diabetes and Obesity (PMID 32077010)
However, officials stress that unapproved versions do not undergo FDA review for safety, effectiveness, or quality before reaching the market, raising the risk of serious health consequences
Cardiovascular outcomes data for Ozempic comes from the SELECT trial, which demonstrated a 20% reduction in major adverse cardiovascular events (heart attack, stroke, cardiovascular death) in patients with established heart disease but without diabetes
She also offers 1 0n 1 coaching
Some liver support formulas combine these ingredients into a standardized blend to simplify dosing and provide complementary mechanisms in one protocol